Trials / Conditions / Lymphoma, Large B-Cell, Diffuse (DLBCL)
Lymphoma, Large B-Cell, Diffuse (DLBCL)
4 registered clinical trials studyying Lymphoma, Large B-Cell, Diffuse (DLBCL) — 2 currently recruiting.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Not Yet Recruiting | A Study to Evaluate MTM-H-001 Injection in Adult Participants With Relapsed or Refractory B-cell Malignancies NCT07476378 | Cancer Institute and Hospital, Chinese Academy of Medical Sciences | N/A |
| Recruiting | A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies NCT06528301 | Umoja Biopharma | Phase 1 |
| Active Not Recruiting | A Study of Zilovertamab Vedotin (MK-2140) in Combination With Cyclophosphamide, Doxorubicin, and Prednisone Pl NCT05406401 | Merck Sharp & Dohme LLC | Phase 2 |
| Unknown | NM-IL-12 (rHuIL-12) In Relapsed/Refractory Diffuse Large B- Cell Lymphoma (DLBCL) Undergoing Salvage Chemother NCT02544724 | Neumedicines Inc. | Phase 2 |